Analyst Ratings for Alterity Therapeutics (ATHE)

ATHE Rating Summary

  |   Expand Research on ATHE
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/3/2025 Benchmark Bob Wasserman New Coverage Speculative Buy
(N/A)		 N/A
(N/A)		 4.80
(3.43)		 -28.54% Details
12/12/2024 Maxim Group Jason McCarthy New Coverage Buy
(N/A)		 8.00
(N/A)		 2.27
(3.43)		 51.1% Details